Search results
Novo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.
Overview of Novo Nordisk pharmaceutical products within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.
Overview of our diabetes medications, obesity medication and also medicines within haemophilia, human growth hormone and hormone replacement therapy.
View a list of Novo Nordisk's current diabetes products along with prescribing information and links to their individual product sites for patients and physicians.
Novo Nordisk offers a variety of insulin options to help people with diabetes control their blood sugar. Here, you can find information on insulin products and diabetes, as well as details on how to save on insulin and sign up for a personalized diabetes management support program.
May 2, 2024 · Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity. Disease areas Products
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Find information about Novo Nordisk medications and devices used to treat diabetes, including insulin and non-insulin medicines.
Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. Its main product is the drug semaglutide , used to treat diabetes under the brand names Ozempic and Rybelsus and obesity under the brand name Wegovy. [6]
Apr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
